2 results match your criteria: "University of Maryland School of Medicine and University of Maryland Medical System[Affiliation]"
Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy.
Blood Adv
January 2022
Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine and University of Maryland Medical System, Baltimore, MD; and.
Vancomycin use in a hospital with vancomycin restriction.
Infect Control Hosp Epidemiol
January 1999
University of Maryland School of Medicine and University of Maryland Medical System, Baltimore 21201, USA.
We evaluated vancomycin use in a hospital with endemic vancomycin-resistant enterococci and a vancomycin restriction program. Only 68% of vancomycin was prescribed appropriately. Inappropriate use was due primarily to empirical therapy.
View Article and Find Full Text PDF